Build a stronger FDA compliance process, monitor active import entries, respond to FDA document requests, and keep registrations, listings, supplier records, and import documentation aligned with the requirements that apply to your products.
FDA electronically screens regulated imports and may request documents, arrange examination or sampling, review compliance information, detain a product, or issue a refusal depending on the facts of a specific entry. ITACS gives the import trade access to entry and line status information and is FDA's preferred method for receiving entry documents.
Our consulting service is designed to help your team organize the regulatory side of that process: identifying which FDA requirements apply, reviewing registrations and listings, coordinating with the customs broker or filer, monitoring available FDA entry status, preparing requested information, and helping the responsible business respond within the deadline stated by FDA.
FDA does not require businesses to hire a private consultant or monitoring company. The service helps businesses manage the FDA requirements and import-entry issues that apply to them. Scope varies substantially by product category and import structure.
A useful monitoring program connects the shipment itself with the underlying registrations, listings, records, labels, and supplier information FDA may evaluate.
For shipments within the engagement, we can track information that is available to the import trade and coordinate action when FDA requests information or takes an entry-related step.
The consulting scope can include the FDA program requirements that create import risk for your particular products and facilities.
FDA's internal screening tools and the systems available to the import trade serve different purposes.
We establish the compliance baseline, define the shipment-monitoring workflow, support active entries, and keep the agreed compliance program current.
We review the products, facilities, import structure, registrations/listings, suppliers, labels, and FDA programs included in the engagement.
We establish the entry-number, broker/filer, document, contact, and escalation process for the shipments being monitored.
We monitor available FDA entry status and coordinate requested documents, exam/sample logistics, Notices of FDA Action, and response strategy as needed.
We maintain the agreed compliance calendar, identify upcoming filing or renewal needs, and adjust the program as products, suppliers, and shipment volume change.
The exact engagement is customized. These are common workstreams for businesses that need ongoing FDA import support.
Review applicable registrations, listings, identifiers, U.S. Agent relationships, supplier programs, labels, and import requirements included in scope.
Check FDA entry/line status using the CBP entry number and track available FDA status changes for monitored entries.
Organize requested invoices, bills of lading, labels, intended-use information, certificates, FSVP records, and other entry documents when applicable.
Coordinate goods-availability information and help the importer, warehouse, sampler, laboratory, and FDA contact stay aligned when examination or sampling occurs.
Review FDA notices, identify the action and deadline shown by FDA, and help prepare an organized response or next-step plan.
Support Food Facility Registration, U.S. Agent, Prior Notice, FSVP, labeling, FCE/SID, and other food-program requirements when included in scope.
Review applicable establishment registrations, listings, identifiers, labels, and import-document issues for covered drugs, devices, and cosmetics.
When an entry is detained or a product or firm is on an Import Alert, help evaluate the FDA action, evidence needed, testing/documentation options, and available response or removal pathway.
The roles can work together, but they are not interchangeable.
| FDA Consultant / Shipment Monitor | Customs Broker / Entry Filer | |
|---|---|---|
| Is the Role Required? | A private FDA consultant is optional. | Use of a licensed customs broker is optional in many circumstances; importers may self-file if eligible, while brokers that transact customs business for others must be licensed by CBP. |
| Primary Focus | FDA regulatory requirements, documentation, registrations/listings, entry status, and FDA response strategy. | CBP entry filing, classification, value, duties, bonds, and transmission of import data through ACE. |
| FDA Entry Data | Can review FDA entry status and documents available through ITACS/Notices and coordinate regulatory responses when authorized. | Transmits entry information to CBP/FDA through ACE and receives system messages as the filer. |
| PREDICT Score | Cannot access or obtain the confidential PREDICT score. | Cannot access or obtain the confidential PREDICT score. |
| FSVP / Label / Registration Work | Can be included in a regulatory consulting scope. | May provide information or referrals, but customs-broker licensing itself does not make the broker the responsible party for every FDA compliance program. |
| Best Workflow | Coordinates regulatory compliance with the importer, facility, and broker. | Coordinates entry filing and customs requirements with the importer and regulatory team. |
Bottom line: A customs broker and an FDA consultant solve different problems. Strong import operations use clear ownership of both customs-entry work and the FDA regulatory obligations that apply to the product.
Monitoring cannot control FDA's decision, but it can reduce the time lost to missing information and unclear ownership.
| Reactive Approach | ProactiveOngoing Monitoring | |
|---|---|---|
| Registration / Listing Review | Reviewed only after an entry problem appears. | Reviewed as part of the compliance baseline and maintenance plan. |
| Entry Status | Checked when the broker or warehouse reports a delay. | Available FDA status is checked during agreed monitoring periods. |
| Document Requests | Documents are assembled after FDA requests them. | Common records and responsible contacts are identified before urgent requests occur. |
| Exam / Sample Coordination | Warehouse, importer, laboratory, and FDA contacts are organized after the hold begins. | Roles and escalation contacts are established in advance where the engagement includes shipment support. |
| Compliance Calendar | Renewals and updates are tracked separately by different teams. | Applicable registrations, listings, renewals, and program tasks can be tracked in one compliance plan. |
| Outcome Guarantee | No guarantee. | No guarantee. FDA retains full authority over entry review, examination, sampling, detention, refusal, and Import Alert decisions. |
The advantage is operational readiness, not control over FDA. Monitoring is most valuable when it shortens the time between an FDA status change or request and an organized business response.
Not every company needs ongoing monitoring. The right structure depends on shipment frequency, product risk, and internal regulatory resources.
| One-Time Project | Ongoing Consulting & Monitoring | |
|---|---|---|
| Best For | A defined registration, label review, Prior Notice filing, detention matter, or specific compliance question. | Businesses with recurring imports, multiple facilities/products, repeated FDA interactions, or a need for a standing compliance resource. |
| Shipment Coverage | Limited to the specific project or entry in scope. | Agreed shipments can be monitored under the ongoing engagement. |
| Compliance Calendar | Not usually included beyond the project. | Can include registration/listing renewals, updates, supplier reviews, and scheduled compliance tasks. |
| FDA Communications | Handled for the specific matter when included. | Standing process for covered FDA communications and entry issues during the service term. |
| Pricing | Quoted for the specific project. | Custom quote based on shipment volume, categories, number of facilities/products, and support level. |
We can scope the engagement around your actual risk and workload rather than forcing every importer into the same package.
Understanding the systems and actions used during FDA import review makes it easier to understand what a shipment status actually means.
Import Trade Auxiliary Communication System — FDA's trade-facing system for entry status, document submission, goods-availability information, certain Notices of FDA Action, and estimated laboratory completion information.
Predictive Risk-based Evaluation for Dynamic Import Compliance Targeting — FDA's internal risk-based analytics tool for screening regulated imports. PREDICT scores are not released to the import trade or public.
Automated Commercial Environment — CBP's electronic trade system through which customs-entry information and FDA-required import data are transmitted.
An FDA notice associated with an import entry that communicates an FDA action, status, request, detention, or refusal-related information for the entry or line.
An FDA admissibility status indicating FDA has no further action on the entry line at that time. It is not an FDA product approval or certification.
FDA may conduct a field examination, label examination, sample collection, or a combination when admissibility cannot be verified electronically or when surveillance or targeting calls for it.
An FDA import action based on the appearance that an article may violate applicable law. The importer or responsible party may have an opportunity to provide evidence regarding admissibility.
FDA's decision to deny admission of an imported article under applicable authority. The next steps depend on the entry and coordination with FDA and CBP.
Import Alerts guide FDA personnel on products, firms, or countries that may be subject to Detention Without Physical Examination. The guidance section of the specific alert identifies evidence relevant to overcoming the appearance of violation or seeking removal.
Advance notice FDA must receive for covered imported food, including animal food, unless an exemption applies. Timing depends on the mode of transportation.
Foreign Supplier Verification Programs — requirements for the FDA-defined FSVP importer of covered imported food, subject to exemptions and modified requirements.
A CBP customs-entry role. It is not automatically the same party as the FSVP importer or a foreign facility's FDA U.S. Agent.
Not every issue causes detention or refusal. These are recurring risk areas that can create additional FDA review, document requests, examination, sampling, or other compliance action.
Incorrect product codes, manufacturer identifiers, registration/listing information, or other entry data can prevent automated validation and increase manual review.
When FDA cannot verify a required establishment registration, listing, or related identifier, entry review can be delayed and some products may be subject to detention or Import Alert criteria.
Covered imported food generally requires FDA Prior Notice unless an exemption applies. Missing or materially incorrect Prior Notice information can create import problems.
For covered food imports, inaccurate FSVP importer information or unavailable FSVP records can result in additional FDA compliance review.
Missing required labeling, undeclared ingredients/allergens, unsupported claims, or category-specific labeling violations may affect admissibility.
FDA states that failure to provide requested entry documentation in a timely manner may delay processing of the entry.
If goods availability, warehouse information, or required access is not coordinated, the examination or sample process can take longer.
When a product or firm is subject to an Import Alert, future entries may be detained without physical examination and require appropriate evidence to overcome the appearance of the listed violation.
These services directly support food import compliance, shipment readiness, and FDA entry issues.
FDA Food Facility Registration and U.S. Agent support for covered foreign food facilities.
U.S. Agent representation for foreign food facilities that are required to register with FDA.
Foreign Supplier Verification Program development and management for covered food importers.
Preparation and filing of Prior Notice for covered imported food shipments.
Review labels, Nutrition Facts, allergens, ingredient declarations, and claims for FDA compliance.
Review Import Alert issues and support an appropriate corrective or removal strategy when available.
FCE registration and scheduled-process filing support for covered acidified and low-acid canned foods.
Explore Food Facility Registration, FSVP, Prior Notice, labeling, FCE/SID, and related food compliance services.
Direct answers about ITACS, PREDICT, customs brokers, FDA document requests, examination, sampling, detention, refusal, Import Alerts, Prior Notice, FSVP, and ongoing compliance support.
The exact scope is customized. A typical engagement can include compliance assessment, registration/listing review, ITACS entry-status monitoring, requested-document coordination, Notice of FDA Action review, examination or sample coordination, food-import requirements such as Prior Notice or FSVP when applicable, labeling/documentation review, and ongoing regulatory planning.
No. FDA does not require an importer or manufacturer to hire a private FDA consultant or shipment-monitoring company. Businesses remain responsible for the FDA requirements that apply to their products, facilities, and imports; a consultant is an optional professional resource for managing those requirements.
For covered entries, monitoring can include FDA entry and line status available through ITACS, document-request status, examination or sampling status, estimated FDA laboratory completion dates when available, Notices of FDA Action, and information coordinated with the customs broker, filer, warehouse, laboratory, importer, or foreign supplier.
No. FDA states that PREDICT scores are not released to customs brokers, entry filers, importers, or the general public. PREDICT is an internal FDA screening tool. We monitor the FDA entry status and communications that are available to the import trade rather than claiming access to a confidential PREDICT score.
PREDICT stands for Predictive Risk-based Evaluation for Dynamic Import Compliance Targeting. FDA uses it as a risk-based analytics tool to electronically screen regulated shipments imported or offered for import into the United States.
ITACS is FDA's Import Trade Auxiliary Communication System. It allows the import trade to check FDA entry status, submit entry documentation, submit goods-availability information for lines selected for examination, and view estimated laboratory completion dates for sampled lines.
At minimum, shipment monitoring normally requires the CBP entry number and enough information to identify the shipment and responsible parties. Depending on the issue, we may also need commercial invoices, bill of lading or airway bill, entry documents, product labels, registration/listing information, Prior Notice confirmation, FSVP records, certificates of analysis, intended-use information, or other documents.
No. No consultant, customs broker, laboratory, or monitoring company can guarantee an FDA May Proceed decision. FDA retains authority to review, examine, sample, detain, refuse, or otherwise act on an import based on the applicable law and the facts of the entry.
It cannot guarantee that FDA will not hold, examine, sample, detain, or refuse a shipment. Monitoring can help identify available status changes earlier, organize requested information, reduce internal communication delays, and support a timely response.
FDA may request documents when admissibility cannot be verified from electronic entry data. ITACS is FDA's preferred method for receiving entry documents. The importer, customs broker, entry filer, or another responsible party can submit documents through ITACS.
FDA states that failure to provide requested entry documentation in a timely manner may result in a delay in processing the entry. The appropriate response time also depends on the specific FDA notice, status, or communication.
Yes. We can help coordinate the regulatory side of the process, including reviewing the FDA status, organizing goods-availability information, coordinating with the warehouse and sampler or laboratory, and tracking status information available through ITACS. FDA controls its own examination and sampling decisions.
Yes. We can review the Notice of FDA Action, identify the stated basis and deadlines, organize relevant records or testing, coordinate with laboratories or other specialists when needed, and help the responsible party prepare a response strategy. The specific options depend on the detention.
Yes. We can review the refusal and related entry history, identify the compliance issue, and help determine next steps. Exportation, destruction, reconditioning, future-entry corrections, or other actions may involve FDA, CBP, the customs broker, legal counsel, and other parties depending on the case.
FDA Import Alerts are guidance to FDA personnel identifying products, firms, or countries that may be subject to detention without physical examination (DWPE). When a product subject to DWPE is offered for import, it can be detained without FDA first physically examining the shipment.
Yes, when a removal pathway is available. We can review the specific Import Alert guidance, entry history, underlying violation, corrective actions, testing or documentation needs, and the type of evidence FDA identifies as relevant. The requirements vary by Import Alert and case.
No. Some Import Alerts or FDA practices may look for a history of compliant entries, but there is no universal rule that every Import Alert requires exactly five shipments. The guidance section of the specific Import Alert and the facts of the case should control the strategy.
A customs broker focuses on CBP customs-entry functions such as classification, value, duties, bonds, and transmission of entry data. An FDA consultant focuses on FDA regulatory requirements, documentation, registrations/listings, entry-status interpretation, and FDA compliance strategy. The roles often work together.
Yes. Depending on the situation, a customs broker or entry filer may submit FDA data and documents. FDA's ITACS guidance states that entry documents can be submitted by the importer, customs broker or entry filer, or another responsible party. Whether the broker provides broader regulatory consulting is a business and scope question.
ACE is CBP's electronic trade system used for entry transmission. We can coordinate with the customs broker or filer and review entry information made available to us, but we do not represent that we have independent access to a client's broker systems unless access or data is specifically provided.
No. We can support FDA-regulated imports involving food and beverages, dietary supplements, cosmetics, drugs, medical devices, animal food and feed, and other FDA-regulated products. The legal requirements and monitoring scope differ by category.
Prior Notice is required for imported food that is subject to FDA's Prior Notice regulation, including animal food, unless an exemption applies. The filing deadline depends on the mode of transportation, and international mail has a separate timing rule.
No. Monitoring does not replace Prior Notice. If the imported food is subject to Prior Notice, the filing must still be submitted and confirmed within the applicable regulatory timeframe.
No. Monitoring and FSVP are separate. When an importer and food are subject to FSVP, the FSVP importer must comply with the applicable supplier-evaluation, verification, recordkeeping, and related requirements regardless of whether shipments are being monitored.
No. FDA states that entities identified as FSVP importers may not be the same entities that serve as importers of record for CBP purposes. The FSVP importer must be determined under FDA's FSVP definition.
Yes, if the engagement includes those entries and we receive the entry number and required shipment information. Amazon fulfillment does not change FDA's import requirements, and Amazon is not a substitute for the importer, customs broker, FSVP importer, or other regulated party where those roles apply.
Yes. Pre-import review can include labels, ingredient declarations, claims, registration/listing information, FSVP records, Prior Notice information, certificates, intended-use information, and other documents relevant to the product and agreed scope.
Response timing depends on the urgency, the service agreement, when the communication is received, and the deadline stated by FDA. Our typical initial response target for routine client inquiries is 24–48 hours, while urgent FDA import matters are triaged based on the actual deadline and circumstances.
Pricing is custom. The quote depends on the FDA product category, number of facilities and products, shipment volume, frequency of monitoring, regulatory complexity, risk history, and whether services such as registration maintenance, FSVP, labeling, detention support, or Import Alert work are included.
FDA does not charge a government fee for hiring a private consulting or shipment-monitoring service. However, separate FDA programs can have their own statutory user fees or government fees; those should be distinguished from professional consulting fees.
Yes. Those services can be included in a customized scope when they apply. The quote should identify exactly which services and shipment volume are covered rather than assuming every importer needs the same package.
Yes. We can work with foreign manufacturers on U.S. FDA compliance and coordinate with their U.S. importer, U.S. Agent, FSVP importer, customs broker, distributor, laboratory, or other parties as appropriate. The foreign manufacturer is not automatically the party responsible for every U.S. importer obligation.
Food Facility Registration information is not a public registration database. Verification generally requires access to the relevant FDA Industry Systems account or registration records. We can review the information supplied by the facility and assist with account or registration issues within the service scope.
No. A consultant can provide regulatory analysis, filing and documentation support, monitoring, and recommendations, but the regulated business remains responsible for the accuracy of its information and for compliance with the laws and regulations that apply to it.
Tell us what you import, how often you ship, which FDA programs apply, and what type of monitoring or regulatory support you need. We will review the scope and prepare a customized recommendation.
